CareDx, Inc. (FRA:1K9)
17.07
-0.34 (-1.98%)
Last updated: Jan 28, 2026, 8:02 AM CET
CareDx Revenue
CareDx had revenue of $100.06M USD in the quarter ending September 30, 2025, with 20.72% growth. This brings the company's revenue in the last twelve months to $358.00M, up 14.46% year-over-year. In the year 2024, CareDx had annual revenue of $333.79M with 19.07% growth.
Revenue (ttm)
$358.00M
Revenue Growth
+14.46%
P/S Ratio
2.92
Revenue / Employee
$550.77K
Employees
650
Market Cap
889.63M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 333.79M | 53.46M | 19.07% |
| Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
| Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
| Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
| Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
| Dec 31, 2019 | 127.07M | 50.50M | 65.95% |
| Dec 31, 2018 | 76.57M | 28.25M | 58.45% |
| Dec 31, 2017 | 48.32M | 7.69M | 18.93% |
| Dec 31, 2016 | 40.63M | 12.49M | 44.37% |
| Dec 31, 2015 | 28.14M | 838.00K | 3.07% |
| Dec 31, 2014 | 27.31M | 5.21M | 23.57% |
| Dec 31, 2013 | 22.10M | 1.65M | 8.05% |
| Dec 31, 2012 | 20.45M | 17.51M | 595.14% |
| Dec 31, 2006 | 2.94M | 2.62M | 799.69% |
| Dec 31, 2005 | 327.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gelsenwasser AG | 3.36B |
| Paul Hartmann AG | 2.44B |
| FRoSTA Aktiengesellschaft | 652.00M |
| tonies SE | 510.38M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |
CareDx News
- 4 days ago - CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Business Wire
- 8 days ago - Insider Sell: Hanna John Walter JR Sells Shares of CareDx Inc (CDNA) - GuruFocus
- 18 days ago - Implied Volatility Surging for CareDx Stock Options - Nasdaq
- 20 days ago - CareDx Preliminary Q4 Revenue Up 25% - Nasdaq
- 20 days ago - CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - Wallstreet:Online
- 20 days ago - CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 25 days ago - CareDx and 10x Genomics to Launch ImmuneScape Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - Wallstreet:Online
- 25 days ago - CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - Business Wire